- Filed
- Apr 29, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 24, 2024 | 50.7M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 51.29M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 51.26M sh |
| Dividends Paid | Q1 2024 · Mar 31, 2024 | $8.11M |
| Dividends Paid | Q1 2024 · Mar 31, 2023 | $8.1M |
| Capex | Q1 2024 · Mar 31, 2024 | $12.84M |
| Capex | Q1 2024 · Mar 31, 2023 | $10.95M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$2.32M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $32.22M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $1.29B |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $1.28B |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $10.03M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $16K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $81.64M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $89.83M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $78.68M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $1.33B |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $1.36B |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $1.38B |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $1.35B |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $379.21M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $396.61M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $915M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $906.72M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $3.27B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $3.31B |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.04 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.26 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.04 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.26 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $90.86M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $85.83M |
| Net Income | Q1 2024 · Mar 31, 2024 | $1.95M |
| Net Income | Q1 2024 · Mar 31, 2023 | $13.16M |
| Operating Income | Q1 2024 · Mar 31, 2024 | $39.68M |
| Operating Income | Q1 2024 · Mar 31, 2023 | $23.28M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $300.1M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $226.24M |